FDA censorship at its finest. Well played, FDA. Well played.
To all dōTERRA Wellness Advocates,
On behalf of the executives, we are grateful for your belief in dōTERRA products and our global mission of bringing greater hope to the world. We have experienced amazing growth together as we’ve shared the wonderful benefits essential oils provide. This growth has required us to improve our systems and processes, and it is now also requiring us to mature how we share dōTERRA products with others.
We want to give you an update on how to present dōTERRA products in a legal and compliant manner. dōTERRA continues to work with the FDA on the concerns they raised with us last September. While we have devoted significant additional resources toward compliance and made progress to address the FDA’s concerns about our Wellness Advocates’ disease and drug claims, we need to see much faster and more far-reaching improvement with our efforts to eliminate inappropriate claims. We want to reiterate our longstanding policy that dōTERRA products are not drugs and may not be promoted to diagnose, treat, cure, or prevent any disease. No one should make any such claim about our products.
Today we are announcing a new policy and accompanying guidelines about how dōTERRA products can and cannot be marketed. These new guidelines are effective immediately.
These reforms are necessary to comply with the law as well as the requests the FDA has made of dōTERRA. Strict compliance has always been a priority for dōTERRA. We know that our Wellness Advocates strive to comply with the law. There may have been some uncertainty as to how to talk about the products and to make legal product claims, but now--with better clarity and clear guidelines--we anticipate absolute adherence. We know that you have the best interest of dōTERRA at heart. Nevertheless, discipline for violating these guidelines and resisting compliance may include a monetary fine, account suspension, or termination. If these changes do not result in the desired outcomes, more changes will likely need to be made. We hope these reforms will not only bring us into stricter compliance, but also empower us to speak with greater certainty about the benefits of dōTERRA’s amazing products. As executives of the company, we have been heartened by the overwhelming and positive responses that we already have received from you to the announcement of these changes on our recent conference calls and trainings.
dōTERRA is an amazing company with wonderful products and good people. Our mission–to bring wellness and hope to those in need—has not changed. We are taking these important steps to preserve the products and opportunities for future generations.
Thank you for your cooperation.
David N. Stirling